IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for ...
Following a careful review of the final proposals received in connection with the potential transaction, the Committee has ...
InMode halts control sale after rejecting final bids including Centroid Sale process shelved as InMode board rejects all final bids, including from Centroid ...
InMode Ltd. is rated a Strong Buy due to its robust balance sheet, proprietary technology, and international growth. Learn more about INMD stock here.
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...
Interested investors are welcome to contact their BTIG salesperson and schedule a meeting. For more information about the event, visit InMode's investor relations site here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results